Isacco Desideri
University of Florence
252 Papers
361 Citations
Isacco Desideri is an academic researcher from University of Florence. The author has contributed to research in topics: Medicine & Radiation therapy. The author has an hindex of 19, co-authored 154 publications.
Chat about Author
Papers
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study).
Icro Meattini,Nadia Pasinetti,Bruno Meduri,Fiorenza De Rose,Maria De Santis,Pierfrancesco Franco,Valentina Lancellotta,F. Rossi,Calogero Saieva,Isacco Desideri,Camilla Delli Paoli,Elisa D'Angelo,Luca Triggiani,Paolo Bastiani,Filippo Alongi,Laura Lozza,Cynthia Aristei,Umberto Ricardi,Marta Scorsetti,Lorenzo Livi +19 more
TL;DR: A real-life study pointed out the significant favorable prognostic role of postmenopausal state and ER positive status on LR occurrence and FSM <1 mm was significantly correlated to a higher chance to experience LR.
9
Impact of radiation dose on patient-reported acute taste alteration in a prospective observational study cohort in head and neck squamous cell cancer (HNSCC)
Ilaria Morelli,Isacco Desideri,Andrea Romei,E. Scoccimarro,Saverio Caini,Viola Salvestrini,Carlotta Becherini,Lorenzo Livi,Pierluigi Bonomo +8 more
- 29 Aug 2023
TL;DR: The authors' analysis supports the influence of dose distribution on the development of TA in HNSCC patients, and the contribution of dose to taste buds and tongue subvolumes remains unclear and worthy of further investigation.
9
A critical review on oligometastatic disease: a radiation oncologist’s perspective
Pietro Pacifico,Riccardo Ray Colciago,Francesca De Felice,Luca Boldrini,Viola Salvestrini,Valerio Nardone,Isacco Desideri,Carlo Greco,Stefano Arcangeli +8 more
TL;DR: In this paper , the authors summarize the major critical features that could drive radiation oncologists toward a better selection of patients, treatments, and study endpoints with the help of a set of practical questions.
Single-Fraction Stereotactic Body Radiotherapy for Oligometastatic Lymph Node Relapse in Prostate Cancer
Mauro Loi,Vanessa Di Cataldo,Giulio Francolini,Pierluigi Bonomo,Laura Masi,Gabriele Simontacchi,Beatrice Detti,Daniela Greto,Isacco Desideri,Lorenzo Livi +9 more
TL;DR: Evaluating the safety and efficacy of a dose-intensive, single-fraction SBRT regimen for lymph node relapse of oligometastatic prostate cancer resulted in promising biochemical control with minimal toxicity.
9